AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 173 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $8,219,000 | +436.5% | 1,003,540 | +262.2% | 0.01% | +400.0% |
Q4 2018 | $1,532,000 | -50.1% | 277,050 | -20.3% | 0.00% | 0.0% |
Q3 2018 | $3,068,000 | +168.9% | 347,470 | +204.0% | 0.00% | +100.0% |
Q2 2018 | $1,141,000 | +48.8% | 114,300 | +42.1% | 0.00% | 0.0% |
Q1 2018 | $767,000 | -35.9% | 80,443 | 0.0% | 0.00% | -50.0% |
Q4 2017 | $1,196,000 | -13.5% | 80,443 | +14.4% | 0.00% | 0.0% |
Q3 2017 | $1,383,000 | +40.8% | 70,312 | +2.9% | 0.00% | +100.0% |
Q2 2017 | $982,000 | +67.3% | 68,355 | +7.1% | 0.00% | 0.0% |
Q1 2017 | $587,000 | -11.6% | 63,804 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $664,000 | +19.6% | 63,804 | +4.0% | 0.00% | 0.0% |
Q3 2016 | $555,000 | +20.9% | 61,350 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $459,000 | -6.1% | 61,350 | +13.0% | 0.00% | 0.0% |
Q1 2016 | $489,000 | +7.5% | 54,303 | +54.0% | 0.00% | 0.0% |
Q4 2015 | $455,000 | +33.4% | 35,254 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $341,000 | -11.7% | 35,254 | -6.1% | 0.00% | 0.0% |
Q2 2015 | $386,000 | +213.8% | 37,527 | +239.2% | 0.00% | – |
Q1 2015 | $123,000 | -4.7% | 11,062 | 0.0% | 0.00% | – |
Q4 2014 | $129,000 | -47.3% | 11,062 | 0.0% | 0.00% | – |
Q3 2014 | $245,000 | -20.2% | 11,062 | 0.0% | 0.00% | -100.0% |
Q2 2014 | $307,000 | – | 11,062 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |